va 061 has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, X; Feng, K; Gong, X; Jiang, Y; Kong, P; Li, X; Liu, C; Liu, W; Sang, Y; Sun, T; Tao, Z; Wang, W; Zhang, L | 1 |
1 other study(ies) available for va 061 and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.
Topics: Androgen Antagonists; Androgens; Cell Line, Tumor; Cell Proliferation; Exosomes; Humans; Male; MicroRNAs; Neoplasm Recurrence, Local; Prostatic Neoplasms, Castration-Resistant; TOR Serine-Threonine Kinases | 2023 |